A B S T R A C T The mechanism by which catecholamines affect ventilation in man is not known. Ventilatory responses to catecholamines were observed in normal subjects before and after adrenergic receptor blockade. Intravenous infusions of norepinephrine and isoproterenol caused significant increases in minute volume and decreases in end-tidal Pcog which were blocked by the administration of propranolol, a beta adrenergic receptor blocker. The hyperventilatory response to hypoxia was not altered by propranolol.
INTRODUCTION
A report that catecholamines affect ventilation (2) was confirmed in man over 50 years ago (3) . Epinephrine, norepinephrine and isoproterenol cause hyperventilation in man (4) (5) (6) . In the present experiments, three studies were undertaken to examine systematically the mechanism by which catecholamines affect ventilation. In the first study, we tested the hypothesis that the stimulation of ventilation by catecholamines may be mediated by beta adrenergic receptors. In the second study, we examined the possibility that stimulation of alpha adrenergic receptors might suppress ventilation (7) . Finally, it has been proposed (8, 9) that the stimulation of ventilation by catecholamines is mediated through arterial chemoreceptors. Therefore in the third study arterial chemoreceptors were suppressed by breathing 100% oxygen (10) to determine whether suppression of chemoreceptors attenuates the ventilatory effects of stimulation of beta adrenergic or alpha adrenergic receptors. METHODS 23 healthy men and one woman, 19-25 yr of age, were studied. A venous catheter was inserted about 3 inches into the basilic vein and connected to a syringe for infusion of drugs.
First study. The effect of propranolol on the hyperventilatory response to norepinephrine, isoproterenol, and hypoxia was tested. 12 men were studied while sitting. The subjects breathed through a low resistance Rahn-Otis sampling valve. Expired gas was collected in plastic Douglas bags. The volume was measured and corrected to standard temperature and pressure. Po2 and P0o2 of the gas in the bags were measured with an IL Ultramicro gas analyzer (Instrumentation Laboratory, Inc., Lexington, Mass.) to allow calculation of oxygen consumption. Po2 and PGO2 were measured in alveolar gas samples. Arterial pressure was determined by auscultation and heart rate was counted from an electrocardiogram.
Measurements were made during i.v. infusions of norepinephrine and isoproterenol, while the subjects were
The journal of Clinical Investigation Volume 51 1972 breathing room air and while they were breathing 10.5% oxygen in nitrogen. These interventions were repeated after i.v. injection of 8 mg of propranolol, followed by an additional 4 mg of propranolol injected 1 hr later. The order of the two infusions (norepinephrine and isoproterenol) and of the two gas mixtures (air and 10.5% oxygen) was reversed in alternate subjects.
The subjects breathed each gas mixture for 3-5 min before control measurements were made. l-norepinephrine bitartrate was infused at a dose of 5 Asg/min (as the base) for 3 min and then at 10 jsg/min for 3 min. Isoproterenol was infused at 1 jsg/min for 3 min and then at 2 Aeg/min for 3 min. There was a 10 min rest period between each infusion to allow ventilation, blood pressure, and heart rate to return to control levels. Measurements were made for 2 min during the control period and during the last 2 min of infusion at each dose level of norepinephrine and isoproterenol.
Breathing 10.5% oxygen causes hyperventilation and hypocapnia. In this study, hypocapnia was prevented during the control period while breathing 10.5%o oxygen by adding carbon dioxide to the inspired gas, as described previously (11) . After the flow rate of carbon dioxide was adjusted during the control period it was not altered during the infusion of the drugs. The amount of expired gas removed by the CO2 analyzer was constant throughout each study (12) .
Second study. The effect of phentolamine on the ventilatory response to phenylephrine was tested. 12 subjects were studied while lying supine. The brachial artery was cannulated with a polyethylene cannula (PE 90) and connected to a pressure transducer and to a syringe for obtaining blood samples. The subjects breathed through a Rudolph valve. In six subjects expiratory minute volume was measured as described above, and in six subjects expired gas was collected in a Tissot spirometer, which was adapted to allow continuous recording of volume.
Each subject was studied during an i.v. infusion of phenylephrine at 40 ,ug/min for 3 min and then at 80 gg/min for 3 min, while breathing room air and 100% oxygen. Observations were also made during i.v. infusion of phentolamine at a dose of 0.5 mg/min; after control measurements, the two doses of phenylephrine were infused while the infusion of phentolamine was continued. In order to determine the response to phentolamine, observations were made during an infusion of phentolamine at 0.5 mg/min for 10 min. The ventilatory effect of angiotensin, infused i.v. at 0.25
,ug/min for 3 min and 0.5 Ag/min for 3 min, was observed in six subjects. The order of the infusions was randomized.
Third study. The effect of breathing 100% oxygen on the ventilatory response to norepinephrine, isoproterenol, and phenylephrine was tested. Six subjects who had participated in the second part of the experiment were studied while lying supine. Measurements were similar to those in the second study.
Each subject was studied during an i.v. infusion of norepinephrine, isoproterenol, and phenylephrine, each drug being infused while breathing room air and 100%o oxygen.
The three drugs were infused as described above. 
RESULTS

Effects of norepinephrine and isoproterenol
Normoxia. Expiratory minute volume increased during infusions of norepinephrine and isoproterenol while breathing room air (Table I) . Changes in alveolar Pco2 and Po2 reflected the changes in minute ventilation (Table II) . Respiratory frequency was not altered by norepinephrine or isoproterenol. Oxygen consumption was not altered by norepinephrine but was increased significantly (P < 0.01) by isoproterenol from 279±+12 (mean ±SE) ml/min at rest to 332±16 during isoproterenol.
Hypoxia. While breathing 10.5% oxygen alveolar Pos decreased but Pco2 was maintained despite hyperventilation by addition of C02 to the gas mixture (Table II) . Hypoxia increased minute volume, and the hyperventilatory responses to norepinephrine and isoproterenol were greater during hypoxia than during normoxia (Tables  I and III) .
Propranolol. Changes in minute volume in response to norepinephrine and isoproterenol were significantly less after propranolol (Tables I and III) . The increase in heart rate during isoproterenol was blocked by propranolol, indicating that propranolol effectively blocked beta adrenergic receptors. Before propranolol the heart rate increased from. 72.0±2.9 at rest to 81.8±2.6 and 107.4±3.9 during 1 and 2 tig/min of isoproterenol (P < 0.001). After propranolol, heart rate was 60.3±2.7 at rest, and 60.8±2.8 and 62.2±2.6 during 1 and 2 lg/ min of .isoproterenol (P > 0.05). In contrast, propranolol did not alter the hyperventilatory response to hypoxia (Table I) nor did it alter the increase in heart rate during hypoxia. Before propranolol. heart rate increased from 72.3±2.9 during normoxia to 87.4±3.0 during hy- Effects of phenylephrine and angiotensin
Phenylephrine decreased expiratory minute volume (Table IV) . Phentolamine blocked this effect of phenylephrine (Tables IV and V) Angiotensin also decreased expiratory minute volume (Table IV) Effects of breathing 100%o oxygen on responses to norepinephrine, isoproterenol, and phenylephrine Increases in minute volume and decreases in alveolar and arterial Pco2 in response to norepinephrine and isoproterenol during normoxia (Tables I, II , and VI) were blocked by breathing 100% oxygen (Tables VI and  VII) . The small decrease in minute volume during phenylephrine was similar while breathing room air and 100% oxygen (Tables VI and VII) . blocks beta adrenergic receptors, suppressed this increase in ventilation. The attenuation of the ventilatory response to norepinephrine and isoproterenol by propranolol is not a nonspecific depression, as indicated by the preservation of the ventilatory response to hypoxia after propranolol. Studies in animals (13) have also shown that the response to hypoxia is preserved after propranolol. The metabolic effect of catecholamines, and its possible relationship to stimulation of ventilation, has received little attention (14) . The increase in metabolism during infusion of catecholamines (15) causes an increase in carbon dioxide production which might account for the increase in ventilation. In this study, however, the increased metabolism must not be the primary mechanism for the hyperventilation. Norepinephrine caused hyperventilation without detectable change in metabolism during the periods of infusions. In addition, the arterial Pco2 decreased significantly in response to the catecholamines; we would expect the Pco2 to increase slightly or remain unchanged if the hyperventilation were a response to increased carbon dioxide production.
Since stimulation of beta adrenergic receptors increased ventilation we considered the possibility that stimulation of alpha adrenergic receptors might suppress ventilation. The findings with phenylephrine tend to support this possibility. It is also possible that the rise in arterial pressure per se may have depressed ventilation (16) (18) . We cannot exclude the possibility that norepinephrine may stimulate ventilation in part by a direct effect on the respiratory center. It is also possible that injection of norepinephrine into the internal carotid artery may increase efferent nerve traffic to the carotid chemoreceptors, similar to the effect noted in response to epinephrine in cats (19) . The efferent nerve traffic might then influence chemoreceptor discharge (20) to produce hyperventilation. This reflex pathway, although initiated in the central nervous system, would nevertheless be susceptible to suppression while breathing 100% oxygen, because of the mediation through carotid chemoreceptors.
It appears therefore from this work and that of others (21) (21) that an infusion of norepinephrine increases the ventilatory response to hypoxia. There appears to be a synergistic response when chemoreceptors are activated simultaneously through a beta a(lrenergic mechanism by the catecholamines and through a lionadrenergic mechanism by hypoxia.
One might speculate on the nature of this beta adrenergic mechanism in light of recent work concerning chemoreceptor physiology. It has been observed that there are two types of cells in the carotid body, type I and type II cells (22) . Type I cells contain abundant stores of catecholamines (23) , and are surrounded by type II cells, which appear to be, or enclose, the chemoreceptor sensors (20) . Type I cells are influenced by efferent excitatory and depressant nerve impulses (19, 20, 24) and the activity of these cells may modify afferent nerve traffic originating in the type II cells (20) . The release of neurotransmitter from the type I cells may have a modulating influence on afferent nerve traffic by an effect on distribution of blood flow (25) or on oxygen consumption of the carotid body (26) . The neurotransmitter may also sensitize chemoreceptors to other stimuli. Catecholamines are known to sensitize frog mechanoreceptors (27) and mammalian muscle spindles (28) so that sensitization of chemoreceptors would not be a unique action. We would suggest that exogenous norepinephrine and isoproterenol as administered in this study may stimulate ventilation by activating the same adrenergic receptor mechanism in the carotid body as the one affected by efferent nerves to the type I cells of the carotid body, and that this mechanism may activate the chemoreceptors or sensitize them to hypoxia. We recognize the speculative nature of this discussion, since the function of type I and type II cells is not certain, but it seems reasonable to conclude that activation of an adrenergic mechanism which may be related to the type I cell may influence chemoreceptor activity which may be structurally related to the type II cell.
